Infants at increased risk for meningococcal disease should receive the recently approved vaccine for bacterial meningitis, according to a proposal approved today by a 13-to-1 vote (1 abstention) by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC).he proposal extends the 2011 infant meningococcal recommendation, which states that high-risk infants aged 9 to 23 months are eligible for the 2-dose MenACWY-D (Menactra) vaccine series.